IperionX Ltd - ADR [IPX] vs United States [UAMY] Detailed Stock Comparison

IperionX Ltd - ADR

NASDAQ
Loading...

United States Antimony Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: IperionX Ltd - ADR wins in 5 metrics, United States Antimony Corporation wins in 10 metrics, with 0 ties. United States Antimony Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric IperionX Ltd - ADR United States Antimony Corporation Better
P/E Ratio (TTM) -24.80 32.66 United States Antimony Corporation
Price-to-Book Ratio 9.83 9.66 United States Antimony Corporation
Debt-to-Equity Ratio 4.12 0.17 United States Antimony Corporation
PEG Ratio -79.10 74.92 United States Antimony Corporation
EV/EBITDA -202.81 -178.20 United States Antimony Corporation
Profit Margin (TTM) 0.00% -11.05% IperionX Ltd - ADR
Operating Margin (TTM) 0.00% -29.62% IperionX Ltd - ADR
Return on Equity -50.42% -5.12% United States Antimony Corporation
Return on Assets (TTM) -28.24% -5.89% United States Antimony Corporation
Free Cash Flow (TTM) $-26.68M $-37.50M IperionX Ltd - ADR
1-Year Return 38.87% 140.27% United States Antimony Corporation
Price-to-Sales Ratio (TTM) N/A 35.50 N/A
Enterprise Value $10.68B $1.36B IperionX Ltd - ADR
EV/Revenue Ratio N/A 34.65 N/A
Gross Profit Margin (TTM) N/A 20.34% N/A
Revenue per Share (TTM) N/A $0 N/A
Earnings per Share (Diluted) $-1.60 $-0.04 United States Antimony Corporation
Beta (Stock Volatility) 1.28 0.10 United States Antimony Corporation
Short % of Float 2.96% 21.66% IperionX Ltd - ADR

IperionX Ltd - ADR vs United States Antimony Corporation Stock Performance Analysis

Loading Price Chart...

IPX
UAMY

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
IperionX Ltd - ADR-3.52%-4.24%-3.90%18.14%2.66%-12.85%
United States Antimony Corporation6.25%-4.23%-13.12%-31.88%50.20%26.14%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
IperionX Ltd - ADR38.87%355.18%491.95%491.95%491.95%491.95%
United States Antimony Corporation140.27%1,970.59%700.00%2,960.87%181.60%935.29%

Performance & Financial Health Analysis: IperionX Ltd - ADR vs United States Antimony Corporation

MetricIPXUAMY
Market Information
Market Cap i$1.08B$1.40B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i181,12411,384,500
90 Day Avg. Volume i338,31811,849,910
Last Close$34.78$7.48
52 Week Range$21.66 - $61.45$1.94 - $19.71
% from 52W High-43.40%-62.05%
All-Time High$61.45 (Jan 26, 2026)$16.71 (Oct 15, 2025)
% from All-Time High-43.40%-55.24%
Growth Metrics
Quarterly Revenue GrowthN/A1.31%
Quarterly Earnings GrowthN/A0.90%
Financial Health
Profit Margin (TTM) i0.00%-0.11%
Operating Margin (TTM) i0.00%-0.30%
Return on Equity (TTM) i-0.50%-0.05%
Debt to Equity (MRQ) i4.120.17
Cash & Liquidity
Book Value per Share (MRQ)$3.22$1.01
Cash per Share (MRQ)$0.19$0.25
Operating Cash Flow (TTM) i$-26,751,632$-9,690,993
Levered Free Cash Flow (TTM) i$-46,281,996$-35,435,596
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: IperionX Ltd - ADR vs United States Antimony Corporation

MetricIPX (Apr 24, 2026)UAMY (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-24.8032.66
Forward P/E i-79.1074.92
PEG Ratio i-79.1074.92
Price to Sales (TTM) iN/A35.50
Price to Book (MRQ) i9.839.66
Market Capitalization
Market Capitalization i$1.08B$1.40B
Enterprise Value i$10.68B$1.36B
Enterprise Value Metrics
Enterprise to Revenue iN/A34.65
Enterprise to EBITDA i-202.81-178.20
Risk & Other Metrics
Beta i1.280.10
Book Value per Share (MRQ) i$3.22$1.01

Financial Statements Comparison: IperionX Ltd - ADR vs United States Antimony Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIPX (2025)UAMY (2025)
Revenue/Sales iN/A39.26M
Cost of Goods Sold iN/A29.38M
COGS % of Revenue i-74.8%
Gross Profit iN/A9.87M
Gross Margin i-25.2%
Research & Development iN/AN/A
Operating Income (EBIT) iN/A-8.88M
Operating Margin i--22.6%
EBITDA iN/A-11.45M
EBITDA Margin i--29.2%
Pre-Tax Income iN/A-4.34M
Pre-Tax Income % of Revenue i--11.1%
Income Tax iN/A0
Income Tax % of Revenue i-0.0%
Net Income (Profit) iN/A-4.34M
Profit Margin i--11.1%

Balance Sheet & Liquidity Metrics

MetricIPX (2025)UAMY (2025)
Cash & Equivalents i33.16M30.49M
Total Current Assets i41.55M54.74M
Total Current Assets % of Revenue i-139.4%
Total Current Liabilities i3.05M10.18M
Total Current Liabilities % of Revenue i-25.9%
Long-Term Debt i1.04M72,486
Long-Term Debt % of Revenue i-0.2%
Total Shareholders Equity i51.34M140.96M
Retained Earnings i-73.88M-45.49M
Retained Earnings % of Revenue i--115.9%
Property, Plant & Equipment i8.60M48,106

Cash Flow Statement Comparison

MetricIPX (2025)UAMY (2025)
Operating Cash Flow i-19.48M-8.01M
Operating Cash Flow % of Revenue i--20.4%
Capital Expenditures i-6.03M-27.80M
Free Cash Flow i-26.68M-37.50M
FCF Margin i--95.5%
Debt Repayment i-423,836-132,252
Common Stock Repurchase iN/A-449,475

Short Interest & Institutional Ownership Analysis

MetricIPXUAMY
Shares Short i855,25529.78M
Short Ratio i2.262.45
Short % of Float i2.96%21.66%
Shares Outstanding i336.32M139.89M
Float Shares i270.53M124.34M
% Held by Insiders i0.00%8.96%
% Held by Institutions i13.09%55.47%
% Held by Public i86.91%35.57%

Dividend Analysis & Yield Comparison: IperionX Ltd - ADR vs United States Antimony Corporation

MetricIPXUAMY
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.40N/A
3-Year Avg Dividend Yield i2.70%N/A
3-Year Total Dividends i$1.20N/A
Ex-Dividend DateMar 01, 2024N/A